Fighting neurodegenerative disease
with new therapies emerging from ground-breaking research relating to repeat associated non-ATG (RAN) Translation
RanTran is a development stage company whose mission is to investigate, develop and commercialize therapies to fight neurodegenerative disease, one of the cruelest killers of all.Learn more about RanTran
Publications, Articles & News
IMPACT OF RESEARCH
The identification and manipulation of pathways that block RAN translation or target RAN proteins using gene therapy can be developed as a platform technology to fight C9orf72 ALS/FTD and a large category of other diseases involving RAN proteins.